Rationale [idcn]
overview [inpr]
Of [spco]
Raloxifene [orch, phsu]
Heart [bpoc]
Trial [resa]
Selective Estrogen Receptor Modulator [horm, phsu]
effects [qlco]
Several [qnco]
cardiovascular risk factor [dsyn]
Associated [qlco]
Reduced [qlco]
Risk [qlco]
Breast Cancer [neop]
Osteoporosis [dsyn]
prevention trials [resa]
Raloxifene [orch, phsu]
Heart [bpoc]
Raloxifene [orch, phsu]
Heart [bpoc]
Study [mnob]
Design [acty]
To [qlco]
Test [lbpr]
Hypothesis [idcn]
Compared [acty]
placebo [topp]
Raloxifene [orch, phsu]
mg day [qnco]
Lower [spco]
Risk [qlco]
Combined [qlco]
End Point [qlco]
coronary [bpoc]
Death [orgf]
Myocardial Infarction [dsyn]
hospitalized [fndg]
Syndromes, Acute Coronary [dsyn]
Myocardial Infarction [dsyn]
Risk [qlco]
Invasive Breast Cancer [neop]
End Point [qlco]
Women [popg]
High Risk [qlco]
Major [qlco]
coronary [bpoc]
Events [evnt]
Based [ftcn]
Established [qlco]
Cardiovascular disease [dsyn]
Multiple [qnco]
risk factors [qnco]
Raloxifene [orch, phsu]
Heart [bpoc]
DOUBLE BLIND [resa]
placebo-controlled [resa]
randomized [resa]
Clinical Trial [resa]
Women [popg]
Aged [orga]
Old [tmco]
Countries [geoa]
Expected [idcn]
To [qlco]
COMPLETED [qlco]
Approximately [qlco]
